Blueprint Medicines (US Rights of Gavreto) Overview

  • Status
  • Private

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Blueprint Medicines (US Rights of Gavreto) General Information

Description

An oral drug used to treat certain cancers caused by abnormal RET genes. The drug therapy is designed to selectively and potently inhibit RET alterations that drive many cancer types.

Contact Information

Website
www.gavreto.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Corporate Office
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Blueprint Medicines (US Rights of Gavreto) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Blueprint Medicines (US Rights of Gavreto)‘s full profile, request access.

Request a free trial

Blueprint Medicines (US Rights of Gavreto) FAQs

  • Where is Blueprint Medicines (US Rights of Gavreto) headquartered?

    Blueprint Medicines (US Rights of Gavreto) is headquartered in .

  • What industry is Blueprint Medicines (US Rights of Gavreto) in?

    Blueprint Medicines (US Rights of Gavreto)’s primary industry is Buildings and Property.

  • Is Blueprint Medicines (US Rights of Gavreto) a private or public company?

    Blueprint Medicines (US Rights of Gavreto) is a Private company.

  • What is the current valuation of Blueprint Medicines (US Rights of Gavreto)?

    The current valuation of Blueprint Medicines (US Rights of Gavreto) is .

  • What is Blueprint Medicines (US Rights of Gavreto)’s current revenue?

    The current revenue for Blueprint Medicines (US Rights of Gavreto) is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process